Impaired glucose tolerance as a disease (Q34384122)

1 August 2017

1 reference

title

Impaired glucose tolerance as a disease (English)

1 reference

1 August 2017

Baron AD

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

American Journal of Cardiology

1 August 2017

published in

1 reference

1 August 2017

volume

88

1 reference

1 August 2017

issue

6A

1 reference

1 August 2017

page(s)

16H-9H

1 reference

Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Glucose intolerance, physical signs of peripheral artery disease, and risk of cardiovascular events: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Is there a glycemic threshold for mortality risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Insulin resistance implications for type II diabetes mellitus and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

The benefits of lowering cholesterol in subjects with mild hyperglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901832-X

10.1016/S0002-9149(01)01832-X

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference